No Data
No Data
Roth MKM Sticks to Their Buy Rating for Aptevo Therapeutics (APVO)
Express News | Roth MKM Maintains Buy on Aptevo Therapeutics, Lowers Price Target to $8
Aptevo Therapeutics Analyst Ratings
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Express News | Reported Earlier, Aptevo Therapeutics Raises $3M In Registered Direct Offering, Featuring 9M Shares And 18M Warrants
Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules
No Data
No Data